{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:39:05Z","timestamp":1789015145172,"version":"build-2803163510"},"reference-count":21,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>ATLL presents more aggressively in US Afro-Caribbean than Japanese patients and continues to have a poor outcome despite modern therapies. AZT-IFN is a reasonable up-front option for aggressive, nonbulky, leukemic ATLL subtypes, resulting in long PFS after a complete response.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017011106","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T12:00:47Z","timestamp":1521115247000},"page":"607-620","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":93,"title":["Epidemiology, clinical features, and outcome of HTLV-1\u2013related ATLL in an area of prevalence in the United States"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-1846","authenticated-orcid":false,"given":"Luis","family":"Malpica","sequence":"first","affiliation":[{"name":"Internal Medicine Program, Jackson Memorial Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isildinha M.","family":"Reis","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[{"name":"Alexander von Humboldt Institute of Tropical Medicine and Infectious Diseases, Department of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros","family":"Lekakis","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine,"},{"name":"Adult Stem Cell Transplant Program,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Komanduri","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine,"},{"name":"Adult Stem Cell Transplant Program,"},{"name":"Sylvester Comprehensive Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harrington","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen N.","family":"Barber","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, and"},{"name":"Department of Cell Biology, University of Miami Miller School of Medicine, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine,"},{"name":"Sylvester Comprehensive Cancer Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"issue":"5838","key":"2019111617352932800_B1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with S\u00e9zary T-cell leukaemia","volume":"294","author":"Poiesz","year":"1981","journal-title":"Nature"},{"issue":"6","key":"2019111617352932800_B2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111617352932800_B3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"issue":"5","key":"2019111617352932800_B4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00042560-199504120-00006","article-title":"Clinical spectrum of HTLV-I in south Florida","volume":"8","author":"Harrington","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"3","key":"2019111617352932800_B5","first-page":"284","article-title":"HTLV-I-associated leukemia\/lymphoma in south Florida","volume":"4","author":"Harrington","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"2019111617352932800_B6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3109\/10428194.2014.964700","article-title":"The incidence of adult T-cell leukemia\/lymphoma among human T-lymphotropic virus type 1 carriers in Japan","volume":"56","author":"Satake","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"2019111617352932800_B7","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"2019111617352932800_B8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"16","key":"2019111617352932800_B9","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/sj.onc.1205329","article-title":"Involvement of IL-2\/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis","volume":"21","author":"Satoh","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"2019111617352932800_B10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2019111617352932800_B11","first-page":"251","article-title":"Adult T-cell leukemia-lymphoma: a clinico-pathologic study of twenty-six patients from Martinique","volume":"7","author":"Plumelle","year":"1993","journal-title":"Hematol Pathol"},{"issue":"24","key":"2019111617352932800_B12","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"issue":"26","key":"2019111617352932800_B13","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111617352932800_B14","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111617352932800_B15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients","volume":"113","author":"Matutes","year":"2001","journal-title":"Br J Haematol"},{"issue":"27","key":"2019111617352932800_B16","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111617352932800_B17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111617352932800_B18","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111617352932800_B19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"32","key":"2019111617352932800_B20","doi-asserted-by":"crossref","first-page":"51981","DOI":"10.18632\/oncotarget.10223","article-title":"Adult T-cell leukemia\/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy","volume":"7","author":"Zell","year":"2016","journal-title":"Oncotarget"},{"issue":"34","key":"2019111617352932800_B21","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/6\/607\/882693\/advances011106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/6\/607\/882693\/advances011106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T17:35:48Z","timestamp":1573925748000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/6\/607\/15791\/Epidemiology-clinical-features-and-outcome-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017011106","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]}}}